Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer. It offers oncolytic virus therapies, utilizing engineered viruses designed to target ovarian cancer, glioblastoma, mesothelioma, head and neck cancer, blood cancers, endometrial cancer, hematologic malignancies and, multiple myeloma and gastrointestinal cancer.